Burnet Institute achieved this week dpun off its trial support company, 360biolabs, to US-buyer BioAgilytix.
Chief executive, Brendan Crabb, says this win means the organisation can channel more funds into its important public health missions.
“Our philosophy is that answers to complex problems can be found in science, both in a technical sense but also social science,”
Some of the things that they do
- getting rid of hepatitis C in Australia,
- preventing childhood stunting in countries such as Papua New Guinea and Myanmar, a risk factor for children’s cognitive development, and
- managing COVID-19 locally and abroad.
How did we get a covid vaccine so quick? Crabb gave the answer in 1 word - money!
No comments:
Post a Comment